ArticleBioinformatics (Oxford, England)2026
PIMO: pathway-based interpretable multiomics interactions for multiomics integration.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationModeling interomics interactions across multiple molecular levels is critical for deciphering the mechanisms underlying complex diseases. Epigenomic and structural alterations, such as DNA methylation and copy number alterations (CNAs), modulate gene expression and collectively influence disease progression and patient survival outcomes. Despite advancements in deep learning-based multiomics analysis, gene-level interactions of interomics have been seldom considered, due to combinational complexity and power, which limits interpretability and mechanistic insight.
resultsWe propose a pathway-based interpretable deep learning multiomics interaction model, PIMO, that explicitly captures regulatory effects across omics layers. Experiments on multiple TCGA cancer datasets showed that PIMO consistently outperformed state-of-the-art baselines in survival analysis, up to 13% increase in the C-index. PIMO provides biologically interpretable analyses that identify important pathways, genes, and interomics interactions with DNA methylation and CNAs. AVAILABILITY AND IMPLEMENTATION: The source code and data are available at https://github.com/datax-lab/PIMO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.